Skip to main content
. 2020 Jul 22;46(4):1514–1524. doi: 10.3892/ijmm.2020.4681

Figure 3.

Figure 3

Anti-migration and anti-invasion effects of trastuzumab on breast cancer cells is enhanced by miR-135b-5p agomir. BT-474 and SK-BR-3 cells were transfected with 1 µg/ml trastuzumab, 50 nM miR-135b-5p agomir or a combination of trastuzumab and miR-135b-5p agomir for 24 h. Cell migration assay was performed to evaluate the migration ability of (A) BT-474 and (B) SK-BR-3 cells. Magnification ×200. Cell invasion assay was performed to evaluate the invasion ability of (C) BT-474 and (D) SK-BR-3 cells. Magnification, ×200. *P<0.05 and **P<0.01 vs. control; ##P<0.01 vs. trastuzumab. miR, microRNA.